Keywords
cardiovascular risk
communication
healthcare
anxiety
How to Cite
Abstract
In press
Background. White-coat hypertension is a controversial issue of a modern cardiovascular medicine. It is a common condition in clinical practice, in which office blood pressure is elevated while out-of-office measurements (ambulatory or home) are normal.
The aim of this review is to address a number of issues related to white-coat hypertension, in particular, its definition, prevalence, etiology, symptoms, and consequences, emphasizing the need to improve diagnosis, management and prognosis of this disease.
Results. Recent studies demonstrate that white-coat hypertension is associated with cardiovascular risk factors, including the progression to sustained hypertension and the development of target organ damage. Timely and accurate diagnosis of white-coat hypertension is incredibly important as it allows postponing its conversion to sustained hypertension and prevents alterations of target organ structure and function. The need for improved patient-doctor interaction to enhance diagnosis and management of white-coat hypertension cannot be overstated. Other measures include exploring standardized measurements, improving communication and relationship establishing between physicians and patients, as well as investigating innovative interventions such as health education and telemedicine. The importance of the understanding of the emotional components contributing to white-coat hypertension are highlighted and strategies to improve patient outcomes through early diagnosis, reduced anxiety, and optimal healthcare experiences are proposed.
Conclusion. A comprehensive approach, encompassing standardized measurements, improved communication, and innovative interventions, is essential for effectively managing white coat hypertension.
Keywords: blood pressure, cardiovascular risk, communication, healthcare, anxiety.
References
Nuredini G, Saunders A, Rajkumar C, Okorie M. Current status of white coat hypertension: where are we? Ther Adv Cardiovasc Dis. 2020;14:1753944720931637. DOI: 10.1177/1753944720931637. PMID: 32580646.
Franklin S, Lutgarde T, Hansen T, O’Brien E, Staessen J. White-Coat Hypertension. Hypertension. 2013; 62:982-7. DOI: 10.1161/HYPERTENSIONAHA.113.01275. PMID: 24041952.
Mancia G, Faccetti R, Bombelli M. White-coat hypertension: pathophysiological and clinical aspects: excellence award for hypertension research 2020. Hypertension. 2021;78:1677-8. DOI: 10.1161/HYPERTENSIONAHA.121.16489. PMID: 34757765.
Spruill T, Pickering T, Schwartz J, Mostofsky E, Ogedegbe G, Clemow L, Gerin W. The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med. 2007;34(1):1-9. DOI: 10.1007/BF02879915. PMID: 17688391.
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697-716. DOI: 10.1161/01.CIR.0000154900.76284.F6. PMID: 15699287.
Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the "white coat effect" in routine practice. Am J Hypertens. 2003;16(6):494-7. DOI: 10.1016/s0895-7061(03)00058-x. PMID: 12799100.
Dolan E, Stanton A, Atkins N, Den Hond E, Thijs L, McCormack P, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004;9(6):307-9. DOI: 10.1097/00126097-200412000-00007. PMID: 15564985.
Fisher M, Blackwell J, Saseen J. What is the best way to identify patients with white-coat hypertension? J Fam Pract. 2005;54(6):549-50. PMID: 15939009.
Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC. Independent predictors of isolated clinic ("white-coat") hypertension. J Hypertens. 2001;19(6):1015-20. DOI: 10.1097/00004872-200106000-00004. PMID: 11403348.
Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40(7):903-18. DOI: 10.1016/0277-9536(94)00155-m. PMID: 7792630.
Bensing JM, Dronkers J. Instrumental and affective aspects of physician behavior. Med Care. 1992;30(4):283-98. DOI: 10.1097/00005650-199204000-00001. PMID: 1556878.
Rao J, Anderson L, Inui T, Frankel R. Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence. Med Care. 2007;45(4):340-9. DOI: 10.1097/01.mlr.0000254516.04961.d5. PMID: 17496718.
Harrington J, Noble L, Newman S. Improving patients’ communication with doctors: a systematic review of intervention studies. Patient Educ Couns. 2004;52(1):7-16. DOI: 10.1016/s0738-3991(03)00017-x. PMID: 14729285.
Street R, Slee C, Kalauokalani D, Dean D, Tancredi D, Kravitz R. Improving physician-patient communication about cancer pain with a tailored education-coaching intervention. Patient Educ Couns. 2010;80(1):42-7. DOI: 10.1016/j.pec.2009.10.009. PMID: 19962845.
Friedman R, Kazis L, Jette A. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4_Pt_1):285-92. DOI: 10.1016/0895-7061(95)00353-3. PMID: 8722429.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.